Time to test antibacterial therapy in Alzheimer’s disease

Cites (258)

Items 201–258 of 258

1. The Alzheimer's disease–protective CD33 splice variant mediates adaptive loss of function via diversion to an intracellular pool
   Shoib Sarwar Siddiqui, Stevan A. Springer, Andrea Verhagen, Venkatasubramaniam Sundaramurthy, Frederico Alisson‐Silva, Weiping Jiang, Pradipta Ghosh, Ajit P Varki · 2017 · Journal of Biological Chemistry
2. Predicting Short‐Term Survival for Patients with Advanced Alzheimer's Disease
   Beverly J. Volicer, Ann C. Hurley, Kathy J. Fabiszewski · 1993 · Journal of the American Geriatrics Society
3. Gut Microbiome in Down Syndrome
   Elena Biagi, Marco Candela, Manuela Centanni, Clarissa Consolandi, Simone Rampelli, Silvia Turroni, Marco Severgnini, Clelia Peano, Alessandro Ghezzo, Maria Scurti et al. · 2014 · PLoS ONE
4. Chlamydia pneumoniae infection and Alzheimer’s disease: a connection to remember?
   Kensuke Shima, Gregor Kuhlenbäumer, Jan Rupp · 2010 · Medical Microbiology and Immunology
5. Detection of bacterial antigens and Alzheimer’s disease-like pathology in the central nervous system of BALB/c mice following intranasal infection with a laboratory isolate of Chlamydia pneumoniae
   Little, Christopher S., Joyce, Timothy A., Hammond, Christine J., Matta, Hazem, Cahn, David, Appelt, Denah M., Balin, Brian J. · 2014 · Frontiers in Aging Neuroscience
6. ChronicPorphyromonas gingivalisinfection accelerates the occurrence of age-related granules in ApoE–/–mice brains
   Sim K. Singhrao, Sasanka S. Chukkapalli, Sophie Poole, Irina M. Velsko, St John Crean, Lakshmyya N. Kesavalu · 2017 · Journal of Oral Microbiology
7. Pharmacokinetics of Acyclovir and Its Metabolites in Cerebrospinal Fluid and Systemic Circulation after Administration of High-Dose Valacyclovir in Subjects with Normal and Impaired Renal Function
   James P. Smith, Stephen Weller, Benjamin W Johnson · 2009 · Antimicrobial Agents and Chemotherapy
8. Short-course versus long-course oral antibiotic treatment for infections treated in outpatient settings: a review of systematic reviews
   Elizabeth E. Dawson-Hahn, Sharon M Mickan, Igho Onakpoya, Nia Wyn Roberts, Matthew P. Kronman, Christopher Butler, Matthew Thompson · 2017 · Family Practice
9. RNA Therapeutics Directed to the Non Coding Regions of APP mRNA, In Vivo Anti-Amyloid Efficacy of Paroxetine, Erythromycin, and N-acetyl cysteine
   Tucker, Stephanie, Ahl, Michelle, Cho, Hyun-Hee, Bandyopadhyay, Sanghamitra, Cuny, Gregory, Bush, Ashley, Goldstein, Lee, Westaway, David, Huang, Xudong, Rogers, Jack · 2006 · Current Alzheimer Research
10. Herpes simplex virus type 2 infection induces AD-like neurodegeneration markers in human neuroblastoma cells
    Henrike Kristen, Soraya Santana, Isabel Sastre, Marı́a Recuero, Maria Jesus Bullido, Jesús Aldudo · 2015 · Neurobiology of Aging
11. Antiherpes Virus–Specific Treatment and Cognition in Schizophrenia: A Test-of-Concept Randomized Double-Blind Placebo-Controlled Trial
    Konasale M. R. Prasad, Shaun M. Eack, Matcheri S. Keshavan, Robert H. Yolken, Satish Iyengar, Vishwajit Laxmikant Nimgaonkar · 2012 · Schizophrenia Bulletin
12. Association between Alzheimer’s Disease and Oral and Gut Microbiota: Are Pore Forming Proteins the Missing Link?
    Sebastian D Aguayo, Christina Maria Anna Pia Schuh, Benjamín Vicente, Luis Gerardo Aguayo · 2018 · Journal of Alzheimer s Disease
13. Failure to detect Chlamydia pneumoniae in brain tissues of Alzheimer’s disease
    David Nochlin, Cheng Mei Shaw, Lee Ann Campbell · 1999 · Neurology
14. Toxoplasma gondiiInfection Potentiates Cognitive Impairments of Alzheimer's Disease in the BALB/c Mice
    Hossein Mahmoudvand, Vahid Sheibani, Saeideh Shojaee, Seyed Reza Mirbadie, Hossein Keshavarz, Khadijeh Esmaeelpour, Ali Reza Keyhani, Naser Ziaali · 2016 · Journal of Parasitology
15. Microbes and Alzheimer' disease: lessons from H. pylori and GUT microbiota.
    Francesco Franceschi, Veronica Ojetti, Marcello Candelli et al. · 2019 · PubMed
16. Early-Stage Inflammation and Experimental Therapy in Transgenic Models of the Alzheimer-Like Amyloid Pathology
    A. Claudio Cuello, Maria Teresa Ferretti, Wanda León, M. Florencia Iulita, Tiziana Melis, Adriana Ducatenzeiler, Martin Alejandro Bruno, Fabio Canneva · 2010 · Neurodegenerative Diseases
17. Plasma neopterin level as a marker of peripheral immune activation in amnestic mild cognitive impairment and Alzheimer's disease
    Daniel Parker, Michelle M. Mielke, Qilu Yu, Paul B. Rosenberg, Alka Jain, Constantine George Lyketsos, Neal S. Fedarko, Esther S. Oh · 2012 · International Journal of Geriatric Psychiatry
18. Toxoplasmosis and Alzheimer: can Toxoplasma gondii really be introduced as a risk factor in etiology of Alzheimer?
    Mahmoud Mahami Oskouei, Faezeh Hamidi, Mahnaz Talebi, Mehdi Farhoudi, Ali Akbar Taheraghdam, Tohid Kazemi, Homayoun Sadeghi‐Bazargani, Esmaeil Fallah · 2016 · Parasitology Research
19. Neurotropic viruses and Alzheimer's disease: a search for varicella zoster virus DNA by the polymerase chain reaction.
    Weihong Lin, Inmaculada Casas, Gordon Keith Wilcock · 1997 · Journal of Neurology Neurosurgery & Psychiatry
20. Minocycline protects PC12 cells against NMDA-induced injury via inhibiting 5-lipoxygenase activation
    Ying Song, Er-Qing Wei, Wei-Ping Zhang, Qiu‐Fu Ge, Jian‐Ren Liu, Mengling Wang, Xiao-Jia Huang, Xin Hu, Zhong Chen · 2006 · Brain Research
21. Increased Inflammatory Response in Cytomegalovirus Seropositive Patients with Alzheimer’s Disease
    Gabriel Westman, David Berglund, Johan Widén, Martin Ingelsson, Olle Korsgren, Lars Lannfelt, Dag Sehlin, Anna Karin Lidehäll, Britt‐Marie Eriksson · 2014 · PLoS ONE
22. Seroprevalence and Serointensity of Latent Toxoplasma gondii in a Sample of Elderly Adults With and Without Alzheimer Disease
    Cynthia E. Perry, Shawn D. Gale, Lance D. Erickson, Eric Wilson, Brent L. Nielsen, John S. K. Kauwe, Dawson W. Hedges · 2015 · Alzheimer Disease & Associated Disorders
23. High avidity HSV-1 antibodies correlate with absence of amnestic Mild Cognitive Impairment conversion to Alzheimer’s disease
    Simone Agostini, Roberta Mancuso, Francesca Baglio, Monia Cabinio, Ambra Hernis, Andrea Saul Costa, Elena Calabrese, Raffaello Nemni, Mario Clerici · 2016 · Brain Behavior and Immunity
24. Continuous intracerebroventricular injection of Porphyromonas gingivalis lipopolysaccharide induces systemic organ dysfunction in a mouse model of Alzheimer's disease
    Kenyu Hayashi, Yu Hasegawa, Yushin Takemoto, Cheng Cao, Hiroto Takeya, Yoshihiro Komohara, Akitake Mukasa, Shokei Kim‐Mitsuyama · 2019 · Experimental Gerontology
25. Evaluation of CSF-Chlamydia pneumoniae, CSF-tau, and CSF-Abeta42 in Alzheimer’s disease and vascular dementia
    Bogusław Paradowski, Malgorzata Jaremko, Tadeusz Dobosz, Jerzy Leszek, Leszek Noga · 2007 · Journal of Neurology
26. Minocycline attenuates Aβ oligomers-induced pro-inflammatory phenotype in primary microglia while enhancing Aβ fibrils phagocytosis
    Ismail Amr El‐Shimy, Ola A. Heikal, Nabila Hamdi · 2015 · Neuroscience Letters
27. Microbiome-Mediated Upregulation of MicroRNA-146a in Sporadic Alzheimer’s Disease
    Yuhai Zhao, Walter J. Lukiw · 2018 · Frontiers in Neurology
28. Alzheimer’s neuroborreliosis with trans-synaptic spread of infection and neurofibrillary tangles derived from intraneuronal spirochetes
    Alan B. MacDonald · 2006 · Medical Hypotheses
29. The effect of chronic periodontitis on serum levels of tumor necrosis factor-alpha in Alzheimer disease.
    Shirin Zahra Farhad, Shahram Amini, Amir Khalilian, Majid Barekatain, Morvarid Mafi, Mehrdad Barekatain, Ehsan Rafei · 2014 · Europe PMC (PubMed Central)
30. Pilot Study of the Reducing Effect on Amyloidosis In Vivo by Three FDA Pre-Approved Drugs Via the Alzheimers APP 5Untranslated Region
    Stephanie C. Tucker, Michelle Ahl, Ashley Ian Bush, David A. Westaway, Xudong Huang, Jack T. Rogers · 2005 · Current Alzheimer Research
31. Challenges and directions for the pathogen hypothesis of Alzheimer’s disease
    Stephen R. Robinson, Curtis B. Dobson, Joseph M. Lyons · 2004 · Neurobiology of Aging
32. Neuroprotective effects of ceftriaxone treatment on cognitive and neuronal deficits in a rat model of accelerated senescence
    Maria A. Tikhonova, Shih-Chun Ho, Anna A. Akopyan, Nataliya G. Kolosova, Jun‐Cheng Weng, Wan-Yun Meng, Chih‐Li Lin, Tamara G. Amstislavskaya, Ying‐Jui Ho · 2017 · Behavioural Brain Research
33. Concurrent neuroborreliosis and alzheimer's disease: Analysis of the evidence
    Miguel A. Pappolla, R. Omar, Bommakanti Saran, Anne C. Andorn, M. Suarez, Charles S. Pavia, A. Weinstein, D. K. Shank, Kenneth L. Davis, Willy Burgdorfer · 1989 · Human Pathology
34. Increased incidence of anti-β-amyloid autoantibodies secreted by Epstein-Barr virus transformed B cell lines from patients with Alzheimer's disease
    Shihua Xu, Felicia Gaskin · 1997 · Mechanisms of Ageing and Development
35. Elevated Epstein-Barr Virus Antibody Level is Associated with Cognitive Decline in the Korean Elderly
    Sung-Mi Shim, Hyo‐Soon Cheon, Chulman Jo, Young Ho Koh, Jihyun Song, Jae‐Pil Jeon · 2016 · Journal of Alzheimer s Disease
36. Lack of Evidence for a Role of HHV-6 in the Pathogenesis of Alzheimer’s Disease
    Simone Agostini, Roberta Mancuso, Francesca Baglio, Monia Cabinio, Ambra Hernis, Franca Rosa Guerini, Elena Calabrese, Raffaello Nemni, Mario Clerici · 2015 · Journal of Alzheimer s Disease
37. Lack of Evidence ofBorreliaInvolvement in Alzheimer's Disease
    Adriana R. Marques, Susan C. Weir, Gary A. Fahle · 2000 · The Journal of Infectious Diseases
38. Does Infection-Induced Immune Activation Contribute to Dementia?
    Tatiana, Jaqueline, Jessica, Allan, Meagan R. Pitcher, Lutiana Roque Simões, João Quevedo, Felipe Dal‐Pizzol · 2015 · Aging and Disease
39. Herpes viruses and Alzheimer's disease: new evidence in the debate
    Balin, Brian J, Hudson, Alan P · 2018 · The Lancet Neurology
40. Infectious Herpes Simplex Virus in the Brain Stem Is Correlated with Reactivation in the Trigeminal Ganglia
    Jessica Doll, Richard Thompson, Nancy M. Sawtell · 2019 · Journal of Virology
41. The Neuro‐Immune Axis: Prospect for Novel Treatments for Mental Disorders
    Aletta D. Kraneveld, Caroline G. M. de Theije, Floor van Heesch, Yuliya E. Borre, Sander de Kivit, Berend Olivier, S. Mechiel Korte, Johan Garssen · 2013 · Basic & Clinical Pharmacology & Toxicology
42. Vaccination prevents latent HSV1 infection of mouse brain
    Woan‐Ru Lin, Roy Jennings, T. L. Smith · 2001 · Neurobiology of Aging
43. A New Avenue for Treating Neuronal Diseases: Ceftriaxone, an Old Antibiotic Demonstrating Behavioral Neuronal Effects
    Tai, Chun-Hwei, Bellesi, Michele, Chen, An-Chih, Lin, Chih-Li, Li, Hsin-Hua, Lin, Pin-Jiun, Liao, Wen-Chieh, Hung, Ching-Sui, Schwarting, Rainer K., Ho, Ying-Jui · 2019 · Behavioural Brain Research
44. The Nervous System and Hepatitis C Virus
    Susan Morgello · 2005 · Seminars in Liver Disease
45. Propionibacterium acnes in the cortex of patients with Alzheimer's disease
    H. H. Kornhuber · 1996 · European Archives of Psychiatry and Clinical Neuroscience
46. Penetration of amoxicillin and potassium clavulanate into the cerebrospinal fluid of patients with inflamed meninges
    Johan Bakken, Johan N. Bruun, Peter Gaustad · 1986 · Antimicrobial Agents and Chemotherapy
47. Possible association of Alzheimer’s disease with HLA-BW15 and cytomegalovirus infection
    Renvoize, E.B., Hambling, M.H., Pepper, M.D., Rajah, S.M. · 1979 · The Lancet
48. Decreased HHV-6 IgG in Alzheimer’s Disease
    Gabriel Westman, Jonas Blomberg, Zhibing Yun, Lars Lannfelt, Martin Ingelsson, Britt‐Marie Eriksson · 2017 · Frontiers in Neurology
49. The 21st century epidemic: infections as inductors of neuro-degeneration associated with Alzheimer’s Disease
    Federico Licastro, Ilaria Carbone, Elena Raschi, Elisa Porcellini · 2014 · Immunity & Ageing
50. Is Alzheimer's disease amyloidosis the result of a repair mechanism gone astray?
    Tyler A. Kokjohn, Chera L. Maarouf, Alex E. Roher · 2011 · Alzheimer s & Dementia
51. Reaction of Amyloid-β Peptide Antibody with Different Infectious Agents Involved in Alzheimer’s Disease
    Aristo Vojdani, Elroy Vojdani, Evan Saidara, Datis Kharrazian · 2018 · Journal of Alzheimer s Disease
52. Proposing BCG Vaccination for Mycobacterium avium ss. paratuberculosis (MAP) Associated Autoimmune Diseases
    Coad Thomas Dow · 2020 · Microorganisms
53. Pathogens as a cause of Alzheimer’s disease
    June Kinoshita · 2004 · Neurobiology of Aging
54. Recurrent systemic infections with Streptococcus pneumoniae do not aggravate the course of experimental neurodegenerative diseases
    Sandra Ebert, Miriam Goos, Lena Rollwagen, Daniel Baake, Wolf‐Dieter Zech, Hermann Esselmann, Jens Wiltfang, Brit Mollenhauer, Reinhard Schliebs, Joachim Gerber et al. · 2009 · Journal of Neuroscience Research
55. Fibronectin staining detects micro-organisms in aged and Alzheimerʼs disease brain
    Jonathan Howard, Geoffrey John Pilkington · 1992 · Neuroreport
56. Deep DNA metagenomic sequencing reveals oral microbiome divergence between monozygotic twins discordant for multiple sclerosis severity
    Anne Isabelle Boullerne, Guy R. Adami, JOEL L. SCHWARTZ, Demetrios D. Skias, Mark Maienschein‐Cline, Stefan J. Green, Douglas L. Feinstein · 2020 · Journal of Neuroimmunology
57. Association of Herpes Viral Infections, Antiherpetic Therapy, and Dementia: Real or Alternative Fact?
    Avindra Nath · 2018 · Neurotherapeutics
58. Infection, inflammation and A lzheimer's disease
    Jonathan M. Schott · 2014 · European Journal of Neurology